Table of Contents Author Guidelines Submit a Manuscript
Behavioural Neurology
Volume 2016, Article ID 1501527, 8 pages
http://dx.doi.org/10.1155/2016/1501527
Research Article

Cox-2 Plays a Vital Role in the Impaired Anxiety Like Behavior in Colchicine Induced Rat Model of Alzheimer Disease

Neurophysiology Laboratory, Department of Physiology, University College of Science and Technology, University of Calcutta, 92 Acharya Prafulla Chandra Road, Kolkata, West Bengal 700 009, India

Received 3 October 2015; Revised 18 December 2015; Accepted 20 December 2015

Academic Editor: João Quevedo

Copyright © 2016 Susmita Sil and Tusharkanti Ghosh. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Wilson, “Microtubules as targets for drug and toxic chemical action: the mechanisms of colchicine and vinblastine,” in The Cytoskeleton—A Target for Toxic Agents, T. W. Clarkson, P. R. Sagar, and T. L. M. Syversen, Eds., pp. 37–52, Plenum Press, New York, NY, USA, 1986. View at Google Scholar
  2. D. F. Emerich and T. J. Walsh, “Cholinergic cell loss and cognitive impairments following intraventricular or intradentate injection of colchicine,” Brain Research, vol. 517, no. 1-2, pp. 157–167, 1990. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Kumar, N. Seghal, S. V. Padi, and P. S. Naidu, “Differential effects of cyclooxygenase inhibitors on intracerebroventricular colchicine-induced dysfunction and oxidative stress in rats,” European Journal of Pharmacology, vol. 551, no. 1–3, pp. 58–66, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Sil, R. Ghosh, M. Sanyal, D. Guha, and T. K. Ghosh, “A comparison of neurodegeneration linked with neuroinflammation in different brain areas of rats after intracerebroventricular colchicine injection,” Journal of Immunotoxicology, 2015. View at Publisher · View at Google Scholar
  5. S. Sil and T. K. Ghosh, “Amelioration of anxiolytic behavior in intracerebroventricular colchicine injected rats by naproxen,” Asian Journal of Pharmaceutical and Clinical Research, vol. 8, no. 5, pp. 189–196, 2015. View at Google Scholar
  6. M. Raghavendra, R. Maiti, S. Kumar, and S. B. Acharya, “Role of Ocimum sanctum in the experimental model of Alzheimer's disease in rats,” International Journal of Green Pharmacy, vol. 3, no. 1, pp. 6–15, 2008. View at Google Scholar · View at Scopus
  7. S. Sil, A. R. Goswami, G. Dutta, and T. Ghosh, “Effects of naproxen on immune responses in a colchicine-induced rat model of Alzheimer's disease,” NeuroImmunoModulation, vol. 21, no. 6, pp. 304–321, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Dargahi, S. Nasiraei-Moghadam, A. Abdi, L. Khalaj, F. Moradi, and A. Ahmadiani, “Cyclooxygenase (COX)-1 activity precedes the COX-2 induction in Aβ-induced neuroinflammation,” Journal of Molecular Neuroscience, vol. 45, no. 1, pp. 10–21, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Yasojima, C. Schwab, E. G. McGeer, and P. L. McGeer, “Distribution of cyclooxygenase-1 and cyclooxygenase-2 mRNAs and proteins in human brain and peripheral organs,” Brain Research, vol. 830, no. 2, pp. 226–236, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Zarghi and S. Arfaei, “Selective COX-2 inhibitors: a review of their structure-activity relationships,” Iranian Journal of Pharmaceutical Research, vol. 10, no. 4, pp. 655–683, 2011. View at Google Scholar · View at Scopus
  11. G. Paxinos and C. Watson, The Rat Brain in Stereotaxic Coordinates, Academic Press, San Diego, Calif, USA, 1986.
  12. A. Ennaceur, S. Michalikova, and P. L. Chazot, “Models of anxiety: responses of rats to novelty in an open space and an enclosed space,” Behavioural Brain Research, vol. 171, no. 1, pp. 26–49, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. P. A. Lawlor and D. Young, “Aβ infusion and related models of Alzheimer dementia,” in Animal Models of Dementia, P. P. De Deyn and D. V. Dam, Eds., vol. 48 of Neuromethods, pp. 347–370, Humana Press, London, UK, 2011. View at Publisher · View at Google Scholar
  14. M. H. V. Kumar and Y. K. Gupta, “Intracerebroventricular administration of colchicine produces cognitive impairment associated with oxidative stress in rats,” Pharmacology Biochemistry and Behavior, vol. 73, no. 3, pp. 565–571, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Kumar, N. Seghal, S. S. V. Padi, and P. S. Naidu, “Differential effects of cyclooxygenase inhibitors on intracerebroventricular colchicine-induced dysfunction and oxidative stress in rats,” European Journal of Pharmacology, vol. 551, no. 1–3, pp. 58–66, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Kumar, P. S. Naidu, N. Seghal, and S. S. V. Padi, “Effect of curcumin on intracerebroventricular colchicine-induced cognitive impairment and oxidative stress in rats,” Journal of Medicinal Food, vol. 10, no. 3, pp. 486–494, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Kumar, N. Seghal, P. S. Naidu, S. S. V. Padi, and R. Goyal, “Colchicines-induced neurotoxicity as an animal model of sporadic dementia of Alzheimer's type,” Pharmacological Reports, vol. 59, no. 3, pp. 274–283, 2007. View at Google Scholar · View at Scopus
  18. A. Kumar, N. Sehgal, P. Kumar, S. S. V. Padi, and P. S. Naidu, “Protective effect of quercetin against ICV colchicine-induced cognitive dysfunctions and oxidative damage in rats,” Phytotherapy Research, vol. 22, no. 12, pp. 1563–1569, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Kumar, S. Dogra, and A. Prakash, “Neuroprotective effects of Centella asiatica against intracerebroventricular colchicine-induced cognitive impairment and oxidative stress,” International Journal of Alzheimer's Disease, vol. 2009, Article ID 972178, 8 pages, 2009. View at Publisher · View at Google Scholar
  20. Y. S. Nakagawa, S. Nakamura, Y. Kaśe, T. Noguchi, and T. Ishihara, “Colchicine lesions in the rat hippocampus mimic the alterations of several markers in Alzheimer's disease,” Brain Research, vol. 408, no. 1-2, pp. 57–64, 1987. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Nakayama and T. Sawada, “Involvement of microtubule integrity in memory impairment caused by colchicine,” Pharmacology Biochemistry and Behavior, vol. 71, no. 1-2, pp. 119–138, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. K. P. Nanry, W. R. Mundy, and H. A. Tilson, “Colchicine-induced alterations of reference memory in rats: role of spatial versus non-spatial task components,” Behavioural Brain Research, vol. 35, no. 1, pp. 45–53, 1989. View at Publisher · View at Google Scholar · View at Scopus
  23. V. Pitchaimani, S. Arumugam, R. A. Thandavarayan et al., “Nootropic activity of acetaminophen against colchicine induced cognitive impairment in rats,” Journal of Clinical Biochemistry and Nutrition, vol. 50, no. 3, pp. 241–244, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Tandon, S. Barone Jr., E. G. Drust, and H. A. Tilson, “Long-term behavioral and neurochemical effects of intradentate administration of colchicine in rats,” NeuroToxicology, vol. 12, no. 1, pp. 67–77, 1991. View at Google Scholar · View at Scopus
  25. E. Ognibene, S. Middei, S. Daniele et al., “Aspects of spatial memory and behavioral disinhibition in Tg2576 transgenic mice as a model of Alzheimer's disease,” Behavioural Brain Research, vol. 156, no. 2, pp. 225–232, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Touma, O. Ambrée, N. Görtz et al., “Age- and sex-dependent development of adrenocortical hyperactivity in a transgenic mouse model of Alzheimer's disease,” Neurobiology of Aging, vol. 25, no. 7, pp. 893–904, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. R. S. Reiserer, F. E. Harrison, D. C. Syverud, and M. P. McDonald, “Impaired spatial learning in the APPSWe + PSEN1ΔE9 bigenic mouse model of Alzheimer's disease,” Genes, Brain and Behavior, vol. 6, no. 1, pp. 54–65, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. G. W. Arendash, D. L. King, M. N. Gordon et al., “Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes,” Brain Research, vol. 891, no. 1-2, pp. 42–53, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. K.-W. Lee, S. H. Lee, H. Kim et al., “Progressive cognitive impairment and anxiety induction in the absence of plaque deposition in C57BL/6 inbred mice expressing transgenic amyloid precursor protein,” Journal of Neuroscience Research, vol. 76, no. 4, pp. 572–580, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. D. Y. Yuk, Y. K. Lee, S. Y. Nam et al., “Reduced anxiety in the mice expressing mutant (N141I) presenilin 2,” Journal of Neuroscience Research, vol. 87, no. 2, pp. 522–531, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. Etoricoxib, December 2015, http://www.old.health.gov.il/units/pharmacy/trufot/alonim/4174.pdf.
  32. Naxen, Naproxen, July 2013, http://www.medsafe.govt.nz/profs/datasheet/n/naxentab.pdf.
  33. M. Lima-Rodrigues, N. Lamas, A. Valle-Fernandes et al., “The selective COX-2 inhibitor Etoricoxib reduces acute inflammatory markers in a model of neurogenic laryngitis but loses its efficacy with prolonged treatment,” Inflammation Research, vol. 59, no. 9, pp. 743–753, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. B. Renner, G. Walter, J. Strauss, M. F. Fromm, J. Zacher, and K. Brune, “Preoperative administration of etoricoxib in patients undergoing hip replacement causes inhibition of inflammatory mediators and pain relief,” European Journal of Pain, vol. 16, no. 6, pp. 838–848, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. T. Zyglewska, R. Sanduja, K. Ohashi, D. S. Loose-Mitchell, S. K. Sanduja, and K. K. Wu, “Inhibition of endothelial cell prostaglandin H synthase gene expression by naproxen,” Biochimica et Biophysica Acta (BBA)—Gene Structure and Expression, vol. 1131, no. 1, pp. 78–82, 1992. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Barrios-Rodiles, K. Keller, A. Belley, and K. Chadee, “Nonsteroidal antiinflammatory drugs inhibit cyclooxygenase-2 enzyme activity but not mRNA expression in human macrophages,” Biochemical and Biophysical Research Communications, vol. 225, no. 3, pp. 896–900, 1996. View at Publisher · View at Google Scholar · View at Scopus
  37. F. Aloisi, “Immune function of microglia,” GLIA, vol. 36, no. 2, pp. 165–179, 2001. View at Publisher · View at Google Scholar · View at Scopus
  38. R. Mitra and R. M. Sapolsky, “Acute corticosterone treatment is sufficient to induce anxiety and amygdaloid dendritic hypertrophy,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 14, pp. 5573–5578, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. M. G. Spina, E. Merlo-Pich, Y. Akwa et al., “Time-dependent induction of anxiogenic-like effects after central infusion of urocortin or corticotropin-releasing factor in the rat,” Psychopharmacology, vol. 160, no. 2, pp. 113–121, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. M. A. Matar, J. Zohar, Z. Kaplan, and H. Cohen, “Alprazolam treatment immediately after stress exposure interferes with the normal HPA-stress response and increases vulnerability to subsequent stress in an animal model of PTSD,” European Neuropsychopharmacology, vol. 19, no. 4, pp. 283–295, 2009. View at Publisher · View at Google Scholar · View at Scopus